Stocktoria

Cordyceps Sunshine Biotech Holdings Co., Ltd. RAJAF

OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2023-10-09

Cordyceps Sunshine Biotech Holdings Co., Ltd. statistics & valuation

Market cap$577.8M
Net margin-12.4%

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-55.80% -1350.90% 85.20% -18.10% -12.40% 20212022202320242025
Gross margin (%)
-20.00% 74.20% 86.80% 72.30% 61.10% 20212022202320242025
Operating margin (%)
-13.60% -778.80% 25.80% -14.70% -11.30% 20212022202320242025
Return on equity (%)
20212022202320242025
Shares outstanding
111.1M 111.1M 111.1M 111.1M 111.1M 20212022202320242025
Net debt ($)
$407372 $407975 20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-15.00% -34.20% 22.40% -4.90% -3.30% 20212022202320242025
Free cash flow margin (%)
-52.90% -741.60% 4.60% -3.00% 20212022202320242025
Debt / equity (×)
20212022202320242025
EPS ($)
$0.00 -$0.01 $0.01 $0.00 $0.00 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Gross margin61.1%72.3%86.8%74.2%-20.0%
Operating margin-11.3%-14.7%25.8%-778.8%-13.6%
Net margin-12.4%-18.1%85.2%-1350.9%-55.8%
FCF margin—-3.0%4.6%-741.6%-52.9%
Return on assets-3.3%-4.9%22.4%-34.2%-15.0%
Return on equity29.0%60.2%-495.1%75.7%178.0%
Debt / equity——-2.84×-0.44×—
Current ratio0.190.120.110.200.39

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.